ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Clinical trials for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cleaning procedure shows promise for fungal allergy sufferers
Disease control Recruiting nowThis study tests whether cleaning mucus plugs from the airways with a bronchoscope and spraying an antifungal medicine (amphotericin B) can help people with allergic bronchopulmonary aspergillosis (ABPA). About 44 adults with active ABPA and mucus plugs will receive the procedure…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New study tests best combo for tough lung fungus
Disease control Recruiting nowThis study looks at people with a lung condition caused by the fungus Aspergillus that has features of both chronic infection and allergy. It compares treatment with just an antifungal pill (itraconazole) versus that pill plus steroids. The goal is to see which approach works bet…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New hope for asthma patients with fungal allergy: benralizumab trial launched
Disease control Recruiting nowThis study tests whether benralizumab can help people with severe asthma and a lung condition called allergic bronchopulmonary aspergillosis (ABPA). The goal is to reduce the number of asthma attacks that need steroids and improve quality of life. The study will enroll 20 adults …
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New biologic drugs aim to tame rare lung allergy in severe asthma patients
Disease control Recruiting nowThis study looks at whether biologic drugs can safely reduce flare-ups in people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a common mold. About 50 adults with severe asthma and a history of asthma attacks will receive …
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC